ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 191 filers reported holding ARRAY BIOPHARMA INC in Q3 2017. The put-call ratio across all filers is 0.75 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $317,000 | +49.5% | 25,805 | +2.0% | 0.00% | +100.0% |
| Q2 2017 | $212,000 | -4.9% | 25,305 | +1.3% | 0.00% | 0.0% |
| Q1 2017 | $223,000 | -13.2% | 24,985 | -14.4% | 0.00% | -50.0% |
| Q4 2016 | $257,000 | +32.5% | 29,185 | +1.4% | 0.00% | 0.0% |
| Q3 2016 | $194,000 | +94.0% | 28,785 | +2.7% | 0.00% | +100.0% |
| Q2 2016 | $100,000 | +20.5% | 28,035 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $83,000 | -29.7% | 28,035 | +0.2% | 0.00% | 0.0% |
| Q4 2015 | $118,000 | -13.9% | 27,980 | -6.7% | 0.00% | 0.0% |
| Q3 2015 | $137,000 | -36.0% | 29,980 | +1.1% | 0.00% | -50.0% |
| Q2 2015 | $214,000 | +9.2% | 29,640 | +11.3% | 0.00% | 0.0% |
| Q1 2015 | $196,000 | +55.6% | 26,640 | +0.3% | 0.00% | +100.0% |
| Q4 2014 | $126,000 | +27.3% | 26,550 | -4.7% | 0.00% | 0.0% |
| Q3 2014 | $99,000 | +106.2% | 27,850 | +164.0% | 0.00% | 0.0% |
| Q2 2014 | $48,000 | – | 10,550 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Advisory Services Network, LLC | 3,442 | $159,000 | 0.01% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |